Andrew R. Boll
Founder of Eton Pharmaceuticals, Inc., Surface Pharmaceuticals, Inc. and Melt Pharmaceuticals, Inc., Andrew R. Boll is an entrepreneur who presently holds the position of Chief Financial Officer & Secretary at Harrow Health, Inc. He is also Member of CFA Institute, Member of Institute of Management Accountants, Inc. and Member of Cfa Society San Diego.
In the past he held the position of Executive Director at Eton Pharmaceuticals, Inc. and Director at Melt Pharmaceuticals, Inc.
Andrew R. Boll received an undergraduate degree from Huron University.
Transactions
Date
Transaction
Value
| 03/31/2023 | 34,442 | Derivative/Non-derivative trans. at $21.16 per share. | 728,793 |
| 03/31/2023 | 90,000 | Derivative/Non-derivative trans. at $6 per share. | 540,000 |
| 01/02/2023 | 9,602 | Derivative/Non-derivative trans. at $14.76 per share. | 141,726 |
| 01/02/2023 | 23,000 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 12/22/2022 | 2,500 | Acquisition at $13.54 per share. | 33,850 |
| 02/19/2022 | 20,605 | Derivative/Non-derivative trans. at $7.87 per share. | 162,162 |
| 02/19/2022 | 50,000 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 04/25/2021 | 49,832 | Derivative/Non-derivative trans. at $8.26 per share. | 411,613 |
| 04/25/2021 | 127,500 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 02/25/2021 | 7,500 | Derivative/Non-derivative trans. at $7.68 per share. | 57,600 |
| 02/25/2021 | 30,000 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 11/22/2019 | 39,000 | 69,810 |
